Nav: Home

Does text messaging help with medication adherence in chronic disease?

February 01, 2016

Medication adherence in chronic disease is poor. Can telephone text messaging help with adherence? A new article published online by JAMA Internal Medicine examines the question in a meta-analysis conducted by Jay Thakkar, F.R.A.C.P., and Clara K. Chow, Ph.D., of The George Institute for Global Health, the University of Sydney, Australia, and coauthors. The meta-analysis included 16 randomized clinical trials to assess the effect of text messaging on medication adherence in chronic disease. The results suggest text messaging was associated with increased odds of medication adherence. However, the authors encourage caution when interpreting their results, in part, because of the reliance on self-reported medication adherence. The authors recommend future studies with a focus on appropriate patient populations, the longevity of the effect and the influence on clinical outcomes.

In a related commentary, R. Brian Haynes, M.D., Ph.D., of McMaster University, Hamilton, Ontario, Canada, and coauthors write: "In summary, future adherence research needs to overcome the common methodological pitfalls that are still plaguing the field. As Thakkar et al show, TM [text messaging] has potential as a widespread, low-cost technology but will need more development and rigorous testing to determine if it has real, enduring and patient-important benefits that are worth the investment."
-end-
To read the full article and related commentary, please visit the For The Media website.

(JAMA Intern Med. Published online February 1, 2016. doi:10.1001/jamainternmed.2015.7667. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures.

Media Advisory: To contact study author Clara K. Chow, Ph.D., email Jenifer Sarver jenifer@sarverstrategies.com. To contact corresponding commentary author R. Brian Haynes, M.D., Ph.D., email bhaynes@mcmaster.ca

The JAMA Network Journals

Related Chronic Disease Articles:

Combating chronic kidney disease with exercise
A University of Delaware research team is combating chronic kidney disease (CKD) with exercise.
Accentuate the positive to reduce risk of chronic disease
People who experience not just positive emotions but a diversity of positive emotions appear to have lower levels of systemic inflammation, which may reduce their risk for chronic diseases such as diabetes and heart disease, according to research published by the American Psychological Association.
Experts argue that obesity is a chronic, relapsing, progressive disease
In a new article, World Obesity Federation experts consider the argument for obesity as a chronic relapsing disease process.
Maternal chronic disease linked to higher rates of congenital heart disease in babies
Pregnant women with congenital heart defects or type 2 diabetes have a higher risk of giving birth to babies with severe congenital heart disease and should be monitored closely in the prenatal period, according to a study published in CMAJ.
Chronic kidney disease may cause diabetes
A team from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a novel link between chronic kidney disease and diabetes.
Discovery of biomarkers for the prognosis of chronic kidney disease
Currently, there is no effective method to predict the prognosis of chronic kidney disease (CKD) patients.
Diabetes more frequent in children with chronic rheumatic disease
Diabetes more frequent in children with chronic rheumatic disease
Are new therapies for Crohn's disease and chronic pancreatitis on the horizon?
Two new studies from CMGH offer insight into new interventions for Crohn's disease and chronic pancreatitis.
Does text messaging help with medication adherence in chronic disease?
Medication adherence in chronic disease is poor. Can telephone text messaging help with adherence?
Identification of a driver of fibrosis in chronic kidney disease
A new study in the inaugural issue of JCI Insight identifies the Wnt pathway modulator Dickkopf-3 as a driver of kidney fibrosis.

Related Chronic Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".